Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion type Assertion NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_head.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion description "[Relevant to its clinical application, muMAb 4D5 may enhance the sensitivity of p185HER2-overexpressing tumor cells to cisplatin, a chemotherapeutic drug often used in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_provenance.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion evidence source_evidence_literature NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_provenance.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion SIO_000772 1679763 NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_provenance.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion wasDerivedFrom befree-20140225 NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_provenance.
- NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_assertion wasGeneratedBy ECO_0000203 NP922948.RAFg7OBcWoha4yeCSvXM44rA3xBHf6XZlx3T4LXXNpSZQ130_provenance.